...
首页> 外文期刊>Cancer biology & therapy >MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells.
【24h】

MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells.

机译:MDA-7调节原发性(未确立的)人神经胶质瘤细胞的细胞生长和放射敏感性。

获取原文
获取原文并翻译 | 示例
           

摘要

We examined the impact of purified bacterially synthesized GST-MDA-7 (IL-24) and ionizing radiation on the proliferation and survival of nonestablished human glioblastoma multiforme (GBM) cells. Glioma cell types expressing mutated PTEN and p53 molecules, activated ERBB1VIII, overexpressing wild type ERBB1 or without receptor overexpression were selected. In MTT assays, GST-MDA-7 caused a dose-dependent reduction in the proliferation of nonestablished glioma cells; however only at higher concentrations did GST-MDA-7 reduce cell viability. The anti-proliferative and cytotoxic effects of GST-MDA-7 were enhanced by radiation in a greater than additive fashion that correlated with JNK1/2/3 activation. The reduction in cell growth and enhancement in cell killing by the combination of GST-MDA-7 and radiation were blocked by an ROS scavenger, N-acetyl cysteine (NAC), a JNK1/2/3 inhibitor SP600125, a pan-caspase inhibitor (zVAD) and by an inhibitor of caspase 9 (LEHD), but not by an inhibitor of caspase 8 (IETD). Low concentrations of either GST-MDA-7 or radiation reduced clonogenic survival, however colony formation ability was significantly further decreased when the two treatments were combined, which was also blocked by inhibition of caspase 9 function. In general agreement with activation of the intrinsic caspase pathway, cell death correlated with reduced BCL-XL expression and with increased levels of the pro-apoptotic proteins BAD and BAX. Inhibition of caspase 9 after combination treatment blunted neither JNK1/2/3 activation nor the enhanced expression of BAD and BAX, but did block caspase 3 cleavage, reduced expression of BCL-XL and inhibition of ERK1/2 activity. In contrast, incubation with NAC blocked JNK1/2/3 activation and cell killing, but not the increases in BAD and BAX expression. These findings argue that after combination treatment JNK1/2/3 activation is a primary pro-apoptotic event and loss of BCL-XL expression and ERK1/2 activity are secondary caspase-dependent processes. This data also argues that GST- MDA-7 induces two parallel pro-apoptotic pathways via ROS-dependent and -independent mechanisms. Infection of primary human astrocytes with a recombinant adenovirus to express MDA-7, Ad.mda-7, but not infection with either Ad.cmv or Ad.mda-7SP- lacking MDA-7 secretion, resulted in the suppression of GBM cell colony formation in soft agar overlay assays, an effect that was enhanced in a greater than additive fashion by radiation. Collectively, our findings demonstrate that MDA-7 reduces proliferation and enhances the radiosensitivity of nonestablished human GBM cells in vitro, and when grown in 3 dimensions, and that sensitization occurs independently of basal EGFR/ERK1/2/AKT activity or the functions of PTEN and p53.
机译:我们检查了纯化的细菌合成的GST-MDA-7(IL-24)和电离辐射对未建立的人成胶质细胞瘤多形(GBM)细胞增殖和存活的影响。选择了表达突变的PTEN和p53分子,激活的ERBB1VIII,过表达的野生型ERBB1或没有受体过表达的胶质瘤细胞类型。在MTT分析中,GST-MDA-7导致未建立的神经胶质瘤细胞的增殖呈剂量依赖性降低。然而,只有在更高的浓度下,GST-MDA-7才会降低细胞活力。通过辐射,GST-MDA-7的抗增殖和细胞毒性作用以与JNK1 / 2/3激活相关的加法方式得以增强。通过GST-MDA-7和辐射的组合,细胞生长的减少和细胞杀伤的增强被ROS清除剂,N-乙酰半胱氨酸(NAC),JNK1 / 2/3抑制剂SP600125,泛半胱氨酸蛋白酶抑制剂阻断(zVAD)和caspase 9抑制剂(LEHD),但不通过caspase 8抑制剂(IETD)。低浓度的GST-MDA-7或放射线会降低克隆形成的存活率,但是当两种治疗方法联合使用时,菌落形成能力会大大降低,这也被caspase 9功能的抑制所阻断。与内在半胱天冬酶途径的激活大体上一致,细胞死亡与减少的BCL-XL表达和促凋亡蛋白BAD和BAX的水平增加相关。联合治疗后对半胱天冬酶9的抑制既不会减弱JNK1 / 2/3的活化,也不会减弱BAD和BAX的表达,但确实能阻止半胱天冬酶3的裂解,降低BCL-XL的表达并抑制ERK1 / 2的活性。相反,用NAC孵育可阻止JNK1 / 2/3活化和细胞杀伤,但不能阻止BAD和BAX表达的增加。这些发现表明,联合治疗后,JNK1 / 2/3激活是主要的促凋亡事件,而BCL-XL表达和ERK1 / 2活性的丧失是继发caspase依赖性过程。该数据还认为,GST-MDA-7通过ROS依赖性和非依赖性机制诱导两个平行的促凋亡途径。用重组腺病毒感染原代人星形胶质细胞以表达MDA-7,Ad.mda-7,但未感染缺少MDA-7分泌的Ad.cmv或Ad.mda-7SP-,导致了GBM细胞集落的抑制在软琼脂覆盖试验中形成,形成的效果通过辐射以大于加和的方式增强。总的来说,我们的研究结果表明,MDA-7可以降低体外未建立的人GBM细胞的增殖并提高其放射敏感性,并且在3维中生长时,其致敏作用与基础EGFR / ERK1 / 2 / AKT活性或PTEN的功能无关和p53。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号